List of Tables
Table 1. Global Probiotic Medication Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Probiotic Medication Market Value by Strain Composition, (US$ Million) & (2024 VS 2031)
Table 3. Global Probiotic Medication Market Value by Dosage Forms, (US$ Million) & (2024 VS 2031)
Table 4. Global Probiotic Medication Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Probiotic Medication Market Competitive Situation by Manufacturers in 2024
Table 6. Global Probiotic Medication Sales (K Units) of Key Manufacturers (2020-2025)
Table 7. Global Probiotic Medication Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Probiotic Medication Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Probiotic Medication Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Probiotic Medication Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Probiotic Medication, Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Probiotic Medication, Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Probiotic Medication, Product Type & Application
Table 14. Global Key Manufacturers of Probiotic Medication, Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Probiotic Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Probiotic Medication as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Probiotic Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Probiotic Medication Sales by Region (2020-2025) & (K Units)
Table 20. Global Probiotic Medication Sales Market Share by Region (2020-2025)
Table 21. Global Probiotic Medication Sales by Region (2026-2031) & (K Units)
Table 22. Global Probiotic Medication Sales Market Share by Region (2026-2031)
Table 23. Global Probiotic Medication Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Probiotic Medication Revenue Market Share by Region (2020-2025)
Table 25. Global Probiotic Medication Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Probiotic Medication Revenue Market Share by Region (2026-2031)
Table 27. North America Probiotic Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Probiotic Medication Sales by Country (2020-2025) & (K Units)
Table 29. North America Probiotic Medication Sales by Country (2026-2031) & (K Units)
Table 30. North America Probiotic Medication Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Probiotic Medication Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Probiotic Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Probiotic Medication Sales by Country (2020-2025) & (K Units)
Table 34. Europe Probiotic Medication Sales by Country (2026-2031) & (K Units)
Table 35. Europe Probiotic Medication Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Probiotic Medication Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Probiotic Medication Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Probiotic Medication Sales by Region (2020-2025) & (K Units)
Table 39. Asia Pacific Probiotic Medication Sales by Region (2026-2031) & (K Units)
Table 40. Asia Pacific Probiotic Medication Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Probiotic Medication Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Probiotic Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Probiotic Medication Sales by Country (2020-2025) & (K Units)
Table 44. Latin America Probiotic Medication Sales by Country (2026-2031) & (K Units)
Table 45. Latin America Probiotic Medication Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Probiotic Medication Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Probiotic Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Probiotic Medication Sales by Country (2020-2025) & (K Units)
Table 49. Middle East and Africa Probiotic Medication Sales by Country (2026-2031) & (K Units)
Table 50. Middle East and Africa Probiotic Medication Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Probiotic Medication Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Probiotic Medication Sales (K Units) by Type (2020-2025)
Table 53. Global Probiotic Medication Sales (K Units) by Type (2026-2031)
Table 54. Global Probiotic Medication Sales Market Share by Type (2020-2025)
Table 55. Global Probiotic Medication Sales Market Share by Type (2026-2031)
Table 56. Global Probiotic Medication Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Probiotic Medication Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Probiotic Medication Revenue Market Share by Type (2020-2025)
Table 59. Global Probiotic Medication Revenue Market Share by Type (2026-2031)
Table 60. Global Probiotic Medication Price (US$/Unit) by Type (2020-2025)
Table 61. Global Probiotic Medication Price (US$/Unit) by Type (2026-2031)
Table 62. Global Probiotic Medication Sales (K Units) by Application (2020-2025)
Table 63. Global Probiotic Medication Sales (K Units) by Application (2026-2031)
Table 64. Global Probiotic Medication Sales Market Share by Application (2020-2025)
Table 65. Global Probiotic Medication Sales Market Share by Application (2026-2031)
Table 66. Global Probiotic Medication Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Probiotic Medication Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Probiotic Medication Revenue Market Share by Application (2020-2025)
Table 69. Global Probiotic Medication Revenue Market Share by Application (2026-2031)
Table 70. Global Probiotic Medication Price (US$/Unit) by Application (2020-2025)
Table 71. Global Probiotic Medication Price (US$/Unit) by Application (2026-2031)
Table 72. Biofarma Group Company Information
Table 73. Biofarma Group Description and Business Overview
Table 74. Biofarma Group Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Biofarma Group Probiotic Medication Product
Table 76. Biofarma Group Recent Developments/Updates
Table 77. Zinereo Pharma Company Information
Table 78. Zinereo Pharma Description and Business Overview
Table 79. Zinereo Pharma Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Zinereo Pharma Probiotic Medication Product
Table 81. Zinereo Pharma Recent Developments/Updates
Table 82. Ab-biotics Company Information
Table 83. Ab-biotics Description and Business Overview
Table 84. Ab-biotics Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Ab-biotics Probiotic Medication Product
Table 86. Ab-biotics Recent Developments/Updates
Table 87. Life-Space Company Information
Table 88. Life-Space Description and Business Overview
Table 89. Life-Space Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Life-Space Probiotic Medication Product
Table 91. Life-Space Recent Developments/Updates
Table 92. i-Health Company Information
Table 93. i-Health Description and Business Overview
Table 94. i-Health Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. i-Health Probiotic Medication Product
Table 96. i-Health Recent Developments/Updates
Table 97. Bayer Company Information
Table 98. Bayer Description and Business Overview
Table 99. Bayer Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Bayer Probiotic Medication Product
Table 101. Bayer Recent Developments/Updates
Table 102. Douglas Pharmaceuticals Limited Company Information
Table 103. Douglas Pharmaceuticals Limited Description and Business Overview
Table 104. Douglas Pharmaceuticals Limited Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Douglas Pharmaceuticals Limited Probiotic Medication Product
Table 106. Douglas Pharmaceuticals Limited Recent Developments/Updates
Table 107. Fujitatsu Co., Ltd. Company Information
Table 108. Fujitatsu Co., Ltd. Description and Business Overview
Table 109. Fujitatsu Co., Ltd. Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Fujitatsu Co., Ltd. Probiotic Medication Product
Table 111. Fujitatsu Co., Ltd. Recent Developments/Updates
Table 112. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Company Information
Table 113. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Description and Business Overview
Table 114. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Probiotic Medication Product
Table 116. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 117. Inner Mongolia Shuangqi Pharmaceutical Co. Ltd. Company Information
Table 118. Inner Mongolia Shuangqi Pharmaceutical Co. Ltd. Description and Business Overview
Table 119. Inner Mongolia Shuangqi Pharmaceutical Co. Ltd. Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Inner Mongolia Shuangqi Pharmaceutical Co. Ltd. Probiotic Medication Product
Table 121. Inner Mongolia Shuangqi Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 122. Wuhan Dongfangzhizi Biotechnology Co., Ltd. Company Information
Table 123. Wuhan Dongfangzhizi Biotechnology Co., Ltd. Description and Business Overview
Table 124. Wuhan Dongfangzhizi Biotechnology Co., Ltd. Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Wuhan Dongfangzhizi Biotechnology Co., Ltd. Probiotic Medication Product
Table 126. Wuhan Dongfangzhizi Biotechnology Co., Ltd. Recent Developments/Updates
Table 127. Beijing Hanmi Pharmaceutical Co., Ltd. Company Information
Table 128. Beijing Hanmi Pharmaceutical Co., Ltd. Description and Business Overview
Table 129. Beijing Hanmi Pharmaceutical Co., Ltd. Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Beijing Hanmi Pharmaceutical Co., Ltd. Probiotic Medication Product
Table 131. Beijing Hanmi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 132. Qingdao Donghai Pharmaceutical Co Ltd Company Information
Table 133. Qingdao Donghai Pharmaceutical Co Ltd Description and Business Overview
Table 134. Qingdao Donghai Pharmaceutical Co Ltd Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Qingdao Donghai Pharmaceutical Co Ltd Probiotic Medication Product
Table 136. Qingdao Donghai Pharmaceutical Co Ltd Recent Developments/Updates
Table 137. Zhejiang Jingxin Pharmaceutical Co. Ltd. Company Information
Table 138. Zhejiang Jingxin Pharmaceutical Co. Ltd. Description and Business Overview
Table 139. Zhejiang Jingxin Pharmaceutical Co. Ltd. Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. Zhejiang Jingxin Pharmaceutical Co. Ltd. Probiotic Medication Product
Table 141. Zhejiang Jingxin Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 142. Northeast Pharmaceutical Company Information
Table 143. Northeast Pharmaceutical Description and Business Overview
Table 144. Northeast Pharmaceutical Probiotic Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Northeast Pharmaceutical Probiotic Medication Product
Table 146. Northeast Pharmaceutical Recent Developments/Updates
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Probiotic Medication Distributors List
Table 150. Probiotic Medication Customers List
Table 151. Probiotic Medication Market Trends
Table 152. Probiotic Medication Market Drivers
Table 153. Probiotic Medication Market Challenges
Table 154. Probiotic Medication Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. Authors List of This Report
List of Figures
Figure 1. Product Picture of Probiotic Medication
Figure 2. Global Probiotic Medication Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Probiotic Medication Market Share by Type: 2024 & 2031
Figure 4. Pathogen/Roxin Removal Type Product Picture
Figure 5. Ecological Restoration Type Product Picture
Figure 6. Immune Modulation Type Product Picture
Figure 7. Metabolic Product Type Product Picture
Figure 8. Global Probiotic Medication Market Value by Strain Composition, (US$ Million) & (2020-2031)
Figure 9. Global Probiotic Medication Market Share by Strain Composition: 2024 VS 2031
Figure 10. Single-strain Preparations Product Picture
Figure 11. Multi-strain Compound Preparations Product Picture
Figure 12. Global Probiotic Medication Market Value by Dosage Forms, (US$ Million) & (2020-2031)
Figure 13. Global Probiotic Medication Market Share by Dosage Forms: 2024 VS 2031
Figure 14. Granules Product Picture
Figure 15. Capsules Product Picture
Figure 16. Tablets Product Picture
Figure 17. Global Probiotic Medication Market Value by Application (2020-2031) & (US$ Million)
Figure 18. Global Probiotic Medication Market Share by Application: 2024 & 2031
Figure 19. Improved Digestion
Figure 20. Diarrhea
Figure 21. Constipation
Figure 22. Others
Figure 23. Global Probiotic Medication Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 24. Global Probiotic Medication Market Size (2020-2031) & (US$ Million)
Figure 25. Global Probiotic Medication Sales (2020-2031) & (K Units)
Figure 26. Global Probiotic Medication Average Price (US$/Unit) & (2020-2031)
Figure 27. Probiotic Medication Report Years Considered
Figure 28. Probiotic Medication Sales Share by Manufacturers in 2024
Figure 29. Global Probiotic Medication Revenue Share by Manufacturers in 2024
Figure 30. Global 5 and 10 Largest Probiotic Medication Players: Market Share by Revenue in Probiotic Medication in 2024
Figure 31. Probiotic Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. Global Probiotic Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 33. North America Probiotic Medication Sales Market Share by Country (2020-2031)
Figure 34. North America Probiotic Medication Revenue Market Share by Country (2020-2031)
Figure 35. United States Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Canada Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Europe Probiotic Medication Sales Market Share by Country (2020-2031)
Figure 38. Europe Probiotic Medication Revenue Market Share by Country (2020-2031)
Figure 39. Germany Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. France Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. U.K. Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Italy Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Russia Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Asia Pacific Probiotic Medication Sales Market Share by Region (2020-2031)
Figure 45. Asia Pacific Probiotic Medication Revenue Market Share by Region (2020-2031)
Figure 46. China Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Japan Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. South Korea Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. India Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Australia Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. China Taiwan Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Southeast Asia Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Latin America Probiotic Medication Sales Market Share by Country (2020-2031)
Figure 54. Latin America Probiotic Medication Revenue Market Share by Country (2020-2031)
Figure 55. Mexico Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Brazil Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Argentina Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Colombia Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Probiotic Medication Sales Market Share by Country (2020-2031)
Figure 60. Middle East and Africa Probiotic Medication Revenue Market Share by Country (2020-2031)
Figure 61. Turkey Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Saudi Arabia Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 63. UAE Probiotic Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 64. Global Sales Market Share of Probiotic Medication by Type (2020-2031)
Figure 65. Global Revenue Market Share of Probiotic Medication by Type (2020-2031)
Figure 66. Global Probiotic Medication Price (US$/Unit) by Type (2020-2031)
Figure 67. Global Sales Market Share of Probiotic Medication by Application (2020-2031)
Figure 68. Global Revenue Market Share of Probiotic Medication by Application (2020-2031)
Figure 69. Global Probiotic Medication Price (US$/Unit) by Application (2020-2031)
Figure 70. Probiotic Medication Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
